These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22469253)

  • 1. Degenerating regenerating torsades de pointes.
    Perrin MJ; Gollob MH; Birnie DH; Nery PB; Keren A
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):e80-3. PubMed ID: 22469253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation followed by torsade de pointes degenerated into ventricular fibrillation spontaneously terminated and restored sinus rhythm.
    Santoro F; Ieva R; Ferraretti A; De Gennaro L; Di Biase M; Brunetti ND
    Int J Cardiol; 2013 Jul; 166(3):e39-40. PubMed ID: 23453872
    [No Abstract]   [Full Text] [Related]  

  • 3. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.
    Da Costa A; Chalvidan T; Belounas A; Messier M; Viallet M; Mansour H; Lamaison D; Djiane P; Isaaz K
    J Cardiovasc Electrophysiol; 2000 Sep; 11(9):990-7. PubMed ID: 11021469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
    Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic ventricular tachycardia, ischaemic ventricular fibrillation, and torsade de pointes: importance of the QT and the coupling interval in the differential diagnosis.
    Rosso R; Hochstadt A; Viskin D; Chorin E; Schwartz AL; Tovia-Brodie O; Laish-Farkash A; Havakuk O; Gepstein L; Banai S; Viskin S
    Eur Heart J; 2021 Oct; 42(38):3965-3975. PubMed ID: 33693589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Torsades de Pointes: a cause of syncope in sinus node dysfunction].
    Velázquez Rodríguez E; Rangel Rojo J; Ortega Sánchez A; Zamudio Villafuerte A; González Gallardo S
    Arch Inst Cardiol Mex; 1998; 68(6):498-505. PubMed ID: 10365226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast and slow torsade de pointes--electrocardiographic characteristics.
    Kukla P; Słowiak-Lewińska T; Szczuka K; Plato A; Bromblik A; Hajduk B; Kluczewski M; Przewor M
    Kardiol Pol; 2004 Apr; 60(4):342-7. PubMed ID: 15226783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Castration is a Rare but Possible Trigger of Torsade de Pointes and Ventricular Fibrillation.
    Hasegawa K; Morishita T; Miyanaga D; Hisazaki K; Kaseno K; Miyazaki S; Uzui H; Ohno S; Horie M; Tada H
    Int Heart J; 2019 Jan; 60(1):193-198. PubMed ID: 30518719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Torsades de pointes].
    Guize L; Iliou MC; Bayet G; Lavergne T; Le Heuzey JY
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):769-76. PubMed ID: 8267505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
    Atkinson D; Dunne A; Parker M
    Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short coupled variant of "torsades de pointes" and sudden death].
    Hentati M; Krichene S; Kechida Z; Chahbani I; Hached L; Grati Z; Charfeddine H; Kammoun S
    Tunis Med; 2004 Jun; 82(6):542-5. PubMed ID: 15517954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
    Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
    Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of torsades de pointes associated with Takotsubo cardiomyopathy as the second insult.
    Yamada Y; Tani T; Homma M; Saito S
    J Electrocardiol; 2011; 44(6):806-9. PubMed ID: 21524756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT interval prolongation and ventricular fibrillation in childhood end-stage renal disease.
    Kim GB; Cho HY; Kwon BS; Bae EJ; Noh CI; Choi JY; Yun YS; Choi Y; Ha JW
    Int J Cardiol; 2008 Jul; 127(3):e126-8. PubMed ID: 17714808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired long QT syndrome and elective anesthesia in children.
    Curry TB; Gaver R; White RD
    Paediatr Anaesth; 2006 Apr; 16(4):471-8. PubMed ID: 16618306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of in-hospital ventricular fibrillation or torsades de pointes in patients with acute symptomatic bradycardia.
    Díaz-Castro O; Puchol A; Almendral J; Torrecilla EG; Arenal A; Martínez-Selles M
    J Electrocardiol; 2004 Jan; 37(1):55-60. PubMed ID: 15132370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors.
    Bertino JS; Owens RC; Carnes TD; Iannini PB
    Clin Infect Dis; 2002 Mar; 34(6):861-3. PubMed ID: 11830802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.